Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1970 2
1973 2
1976 2
1978 4
1983 1
1985 1
1991 1
2004 1
2006 1
2008 3
2009 1
2010 1
2012 2
2013 3
2016 2
2017 1
2018 1
2019 2
2020 2
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for johannes, k
Search for Johaness K instead (1 results)
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade.
Yoo KJ, Johannes K, González LE, Patel A, Shuptrine CW, Opheim Z, Lenz K, Campbell K, Nguyen TA, Miriyala J, Smith C, McGuire A, Tsai YH, Rangwala F, de Silva S, Schreiber TH, Fromm G. Yoo KJ, et al. Among authors: johannes k. J Immunol. 2022 Aug 1;209(3):510-525. doi: 10.4049/jimmunol.2101175. Epub 2022 Jul 11. J Immunol. 2022. PMID: 35817517 Free PMC article.
Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy.
Fromm G, de Silva S, Johannes K, Patel A, Hornblower JC, Schreiber TH. Fromm G, et al. Among authors: johannes k. J Immunother Cancer. 2018 Dec 18;6(1):149. doi: 10.1186/s40425-018-0454-3. J Immunother Cancer. 2018. PMID: 30563566 Free PMC article.
Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2+ T Cells in the Presence of Costimulation by CD28 or NKG2D.
Lai AY, Patel A, Brewer F, Evans K, Johannes K, González LE, Yoo KJ, Fromm G, Wilson K, Schreiber TH, de Silva S. Lai AY, et al. Among authors: johannes k. J Immunol. 2022 Oct 15;209(8):1475-1480. doi: 10.4049/jimmunol.2200185. Epub 2022 Sep 12. J Immunol. 2022. PMID: 36096643 Free PMC article.
Patterned enteroscopy balloon design factors influence tissue anchoring.
Bowen LK, Johannes K, Zuetell E, Calahan KN, Edmundowicz SA, Long R, Rentschler ME. Bowen LK, et al. Among authors: johannes k. J Mech Behav Biomed Mater. 2020 Nov;111:103966. doi: 10.1016/j.jmbbm.2020.103966. Epub 2020 Jul 28. J Mech Behav Biomed Mater. 2020. PMID: 32810654
Deletional tolerance mediated by extrathymic Aire-expressing cells.
Gardner JM, Devoss JJ, Friedman RS, Wong DJ, Tan YX, Zhou X, Johannes KP, Su MA, Chang HY, Krummel MF, Anderson MS. Gardner JM, et al. Among authors: johannes kp. Science. 2008 Aug 8;321(5890):843-7. doi: 10.1126/science.1159407. Science. 2008. PMID: 18687966 Free PMC article.
39 results